Journal
Jornal
RDF description of ABC: Heart Failure & Cardiomyopathy - https://brcris.ibict.br/individual/journ_ec6c6af6-0d9b-43a5-ab36-38baba163c7d
Diabetic Cardiomyopathy and Heart Failure
Pharmacokinetics, Mechanism of Action, and Adverse Effects of the Main Drugs Used to Treat Heart Failure: A Practical Overview for the Clinical Cardiologist
Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based Approach
Myocarditis: Whole Heart Involvement Revealed by Cardiac Magnetic Resonance Mapping. A Case-control Study
When to Suspect Infiltrative or Storage Cardiomyopathy in Patients with HFpEF?
Echocardiography in Heart Failure with Preserved Ejection Fraction: From Primary Care to Tertiary Hospitals
HFpEF: Evidence from Recent Clinical Trials and New Perspectives
Heart failure with preserved ejection fraction and cancer
Rapid Sequencing of Foundational Treatment for HFrEF: The Innovative Proposal of John McMurray and Milton Packer
Cardiovascular Rehabilitation in Patients with Cancer
Diuretics and Clinical Management of Congestion in Heart Failure: A Review
Acute Myocarditis in Childhood and Adolescence in the Covid-19 Era
Atuação Multidisciplinar na Assistência de Pacientes com Insuficiência Cardíaca em Meio à Pandemia: Lições Aprendidas
Comprehensive Echocardiogram: What is it? For which Patients?
SGLT2 Inhibitors and Sacubitril-Valsartan: How Trial Results will Revolutionize the Treatment of Heart Failure with Mildly Reduced Ejection Fraction
Overlapping Etiologies in a Young Patient with Severe Myocarditis: A Case Report
The Role of the Heart Failure Specialist: Benefits for Both the Patient and the Cardiology Community
Beyond the Disease - History of the House for Patients with Chagas Disease and Heart Failure of Pernambuco (Casa do Portador de Doença de Chagas e Insuficiência Cardíaca de Pernambuco)/PROCAPE-UPE/Brazil
Advances in Clinical Practice, Diagnosis and Treatment of Chronic Chagas? Heart Disease
When to Suspect Advanced Heart Failure in Heart Failure with Preserved Ejection Fraction?
Heart Transplantation in Patients with Chemotherapy-Induced Cardiotoxicity
Invasive Cardiopulmonary Hemodynamic Assessment in Patients with Advanced Heart Failure: How to Interpret?
Pathophysiological Bases of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction and Implications for Management
New Drugs for Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat and Omecamtiv Mecarbil
Cardiovascular Burden of COVID-19 and the Post-Covid Era
Genetic Testing in Amyloidosis: For Whom?
Advanced Heart Failure in the Cancer Patient
Association of Age with Optimal Medical Therapy in Patients with Chronic Heart Failure
Rethinking the Definition of Heart Failure Based on Ejection Fraction: Reflections with Impact on Therapy
HFREF Pharmacological Treatment Sequencing: The Traditional Approach
Preoperative Evaluation and Perioperative Complications in Patients with Cancer and Ventricular Dysfunction
New Paradigms in Cardiac Amyloidosis: The Current Experience of the Northeast Region of Brazil
The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice
Registry of Transthyretin Amyloidosis in the State of São Paulo (REACT-SP)
Diagnosis of Heart Failure with Preserved Heart Failure in the Office Setting: How to Assemble this Puzzle?
Diuretics In Stable Outpatients with Mild Heart Failure - May I Discontinue Them?
Cognitive Frailty and Depressive Symptoms in Heart Transplant Candidates: Rational and Study Design
What is the Importance of Clinical Clues, and How can we Avoid Mistakes in Following Them?
Assessment of the efficacy of different cumulative doses of doxorubicin for the induction of a dilated cardiomyopathy model in rats
How to Anticoagulate Patients with Heart Failure and Cancer?
Swan-Ganz Catheter and Lack of Evidence: Does it Reflect Clinical Practice?
Flowchart for Treatment of Heart Failure with Preserved Ejection Fraction
Genetic Counseling and Pedigree in Cardiomyopathies - the Role of the Clinical Geneticist
Possible Mechanisms of Action of SGLT2 Inhibitors in Heart Failure
Invasive Hemodynamic Monitoring in the Diagnosis of Heart Failure with Preserved Ejection Fraction
The Importance of Controlling Comorbidities in HFpEF and How They Influence Disease Evolution
Disfunção de ventrículo direito no paciente com câncer
Familial Transthyretin Cardiac Amyloidosis with Homozygous Val122Ile Mutation Mimicking Hypertrophic Cardiomyopathy
Doenças Pericárdicas em Pacientes Oncológicos
Essential Therapy for Heart Failure with Preserved Ejection Fraction in 2022
Critical Analysis and Applicability of Imaging Methods in Monitoring and Diagnosing Ventricular Dysfunction in Patients with Cancer
Toxic Cardiomyopathies: Alcohol, Amphetamines, and Anabolic Steroids
The Heart-Gut Microbiome Intersection in Heart Failure
The Impact of Clonal Hematopoiesis of Indeterminate Potential on Advanced Heart Failure
Biologic Left Ventricular Assist: A New Strategy for Patients with Advanced Heart Failure with Pulmonary Hypertension
Left Atrial Cardiomyopathy as a Generator of Heart Failure with Preserved Ejection Fraction
Heart Failure Due to Anomalous Pulmonary Vein Connection Associated with Atrial Septal Defect
Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Conduction Disturbances Leading to Heart Failure - What Clinicians Need to Know
Disease Modifying Therapies for Transthyretin Amyloid Cardiomyopathy
Acute Inspiratory Muscle Training Modifies Hemodynamic Indices in Patients with Heart Failure with Preserved Ejection Fraction
Heart Failure with Preserved Ejection Fraction and Cardiac Amyloidosis: Implications for Treatment
Physical Training in Heart Failure with Preserved Ejection Fraction
The Challenge of HFpEF Diagnosis in Brazil
The Role of Biomarkers in Heart Failure with Preserved Ejection Fraction
The EMPEROR-Preserved Trial: Results that Innovate the Treatment of Heart Failure with Preserved Ejection Fraction
Long-Term Ventricular Assist Devices - Main Complications in Contemporary Clinical Practice
Lessons Learned from Community Studies of HFpEF - The Digitalis Study
Symptomatic Acute Myopericarditis after Pfizer Vaccine against COVID-19
Hypertension in Patients with Cancer as a Predictor of Ventricular Dysfunction